baber/WOPTO huggingface dataset:
Patent AT-E239805-T1 (AT)
Inventor: WILLEMIN GERARD
IPC: G02C7/02
Filed: 1999-09-02
Granted: 2003-05-15
Abstract: The invention concerns a support of the type comprising at least a first base (13), and, borne by the latter, for maintaining such an optical lens (10) at its edge (11), at least three support pins (14A, 14B). The invention is characterized in that the base comprises, for its own support, a plane support surface (16) whereof the peripheral outline (P1) is globally circular, its radial dimension (D1) along a particular radius (R) of said support surface (16) is at least equal to its axial dimension (D2) perpendicularly to the plane thereof. The invention is particularly useful for maintaining an optical lens in a processing apparatus using spin coating technique.
Patent AT-E251181-T1 (AT)
Inventor: KUFER PETER
IPC: G01N33/53
Filed: 1999-07-28
Granted: 2003-10-15
Abstract: The present invention relates to a multifunctional compound, produceable in a mammalian host cell as a secretable and fully functional heterodimer of two polypeptide chains, wherein one of said polypeptide chains comprises, as the only constant region domain of an immunoglobulin heavy chain the CH1-domain and the other polypeptide chain comprises the constant CL-domain of an immunoglobulin light chain, wherein said polypeptide chains further comprise, fused to said constant region domains at least two (poly)peptides having different receptor or ligand functions, wherein further at least two of said different (poly)peptides lack an intrinsic affinity for one another and wherein said polypeptide chains are linked via said constant domains. Preferably, said domains, having receptor or ligand function, are in the format of a scFv-fragment and/or are immuno-modulating effector molecules. Most preferably, said scFV-fragment comprises the VH and the VL regions of the murine anti 17-1A antibody M79, the VH and the VL regions of the anti-Lewis Y antibody, as shown in Fig. 6, or the VH and the VL regions of the anti-CD3 antibody TR66 and/or said immuno-modulating effector molecule comprises cytokines or chemokines. Furthermore, the present invention relates to polynucleotides encoding said polypeptide chains as well as vectors comprising said polynucleotides and host cells transformed therewith as well as the use of the above embodiments for the production of said multifunctional compounds. In addition, pharmaceutical and diagnostic compositions are provided, comprising any of the afore-described multifunctional compounds, polynucleotides or vectors. Described is also the use of the afore-mentioned multifunctional compound for preventing and/or treating malignant cell growth, related to malignancies of hemapoietic cells or to solid tumors.
Patent AT-E290579-T1 (AT)
Inventor: MUELLER HEINZ
IPC: C09K8/06
Filed: 1999-11-06
Granted: 2005-03-15
Abstract: A process for imparting lubricity to an aqueous drilling fluid used in geological exploration involving: (a) providing an aqueous drilling fluid; (b) providing a lubricant component containing a partial glyceride of predominantly unsaturated fatty acids having from about 16 to 24 carbon atoms; and (c) introducing the partial glyceride into the aqueous drilling fluid.
Patent AT-E261182-T1 (AT)
Inventor: TIP ANDRIES CORNELIS
IPC: H01G9/20
Filed: 1999-06-15
Granted: 2004-03-15
Abstract: Method for manufacturing a photovoltaic element comprising a layered structure of at least a first electrically conductive layer, a layer of crystalline metal oxide semiconductor material deposited thereon, a second electrically conductive layer and an electrolytic liquid between the layer of semiconductor material and the second electrically conductive layer, wherein at least one of the electrically conductive layers is transparent and is deposited on a transparent substrate, comprising of (i) providing a layer of crystalline metal oxide semiconductor material on a first electrically conductive layer and providing an electrically conductive layer; (ii) arranging an edge zone of a thermoplastic adhesive material round the deposited layer of semiconductor material; (iii) arranging the second respectively the first electrically conductive layer over said edge zone; (iv) locally heating at least a first part of the edge zone and simultaneously exerting pressure locally on the surface of this first part to cause the adhesive to adhere to the first and second conductive layer in order to form a partially bounded space; (v) introducing an electrolytic liquid into said space, wherein the second electrically conductive layer is spatially separated by this liquid from the layer of semiconductor material; and (vi) locally heating the remaining part of the edge zone not yet heated in the fourth step and simultaneously exerting pressure locally on the surface of this remaining part to cause the adhesive to adhere to the first and second conductive layer and to enclose the liquid.
Patent AT-E331401-T1 (AT)
Inventor: BUSCH LAUPER KARIN
IPC: H04L9/32
Filed: 1999-12-15
Granted: 2006-07-15
Abstract: Method for verifying in a mobile device ( 13 ) the authenticity of electronic partner certificates issued by a certification authority. Said mobile device ( 13 ) has an identification module ( 16 ) (SIM or WIM). Said issued certificates are verified with the certificate of the certification authority. A reference to said electronic certificate of the certification authority is stored in a second module ( 14 ) that is connected with said mobile device ( 13 ). Advantages: the second module can be distributed independently from the first module and from the mobile device.
Patent DE-00993875-T1 (DE)
Title: Kit zur behandlung von malaria die chloroquin und 3-(1-(((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)-ethylidene)-dihydro-2(3h)furanone enthält
Inventor: PINTO FRANCIS JOSEPH
IPC: A61K31/47
Filed: 2000-08-30
Abstract: Kombinationspackung für die Behandlung von P.-vivax-Malaria, umfassend:  a) eine vorbestimmte Dosis eines ersten Anti-Malaria-Mittels, nämlich Chloroquin,  b) eine vorbestimmte Dosis eines zweiten Anti-Malaria-Mittels, nämlich 3-[1-[[4-[(6-Methoxy-8-chinolinyl)amino]pentyl]amino]ethyliden]-dihydro-2(3H)furanon,  c) ein Anweisungsmaterial, das Anweisungen zum Verabreichen der beiden Anti-Malaria-Mittel während des Behandlungszeitraums enthält.
Patent DE-15180670-T1 (DE)
Title: Spielsystem, Spielvorrichtung, Speichermedium mit darauf gespeichertem Spielprogramm und Verfahren zum Spieldatenaustausch
Inventor: OE TORU
IPC: A63F13/45
Filed: 2004-04-27
Abstract: Verfahren zum Durchführen drahtloser Funkkommunikation in einer Spielvorrichtung, wobei das Verfahren enthält: alternatives Wiederholen des Funktionierens der Spielvorrichtung in einem ersten Modus und einem zweiten Modus, worin im ersten Modus die Spielvorrichtung andere Spielvorrichtungen sucht, die im zweiten Modus funktionieren; worin im zweiten Modus die Spielvorrichtung Suchen von anderen Spielvorrichtungen empfängt, die im ersten Modus funktionieren; und worin die Länge von mindestens einer der ersten Periode, in der die Spielvorrichtung im ersten Modus funktioniert und der zweiten Periode, in der die Spielvorrichtung im zweiten Modus funktioniert, zufällig bestimmt wird.
Patent DE-18712696-T1 (DE)
Title: Wasserdichte verschlussvorrichtung, behälter mit einer verschlussvorrichtung, verfahren zur herstellung einer verschlussvorrichtung
Inventor: CONSOLARO ROBERTO
IPC: A61J1/14
Filed: 2018-02-21
Abstract: Verfahren zum Ausbilden einer Verschlussvorrichtung (100, 200) für einen aseptischen Behälter, umfassend die folgenden Schritte:- Injizieren eines ersten Schutzmaterials in eine erste Form zum Ausbilden einer Hülle (10, 210) und eines Schutzelements (11, 211), welches mit der Hülle im Einklang mit einem Verbindungsbereich (14, 214) verbunden ist,- Injizieren eines zweiten Materials, welches dazu geeignet ist, innerhalb der Hülle (10, 210) gestanzt zu werden, um einen Kern (220) auszubilden,- während des Schritts des Injizierens des ersten Materials, Erzeugen eines Sollbruchbereichs im Einklang mit dem Verbindungsbereich (14, 214),- während des Schritts des Injizierens des zweiten Materials, Erreichen eines Drucks, welcher dazu geeignet ist, das zweite Material zu veranlassen, durch den Sollbruchbereich, teilweise offen, hindurch zu treten, um ein vorstehendes Element (21, 221) zu erzeugen, welches wenigstens teilweise das Schutzelement (11, 211) einbettet und von dem Kern (20, 220) durch den Verbindungsbereich (14, 214) getrennt ist.
Patent DE-150795-T1 (DE)
IPC: F02M35/10
Filed: 1985-01-21
Abstract: Each intake passage of the manifold is divided into two symmetrical passages (3 & 3') which taper gently down toward a restriction (6) beneath the point (7) where fuel is injected. The axes of the two passages converge in V-formation toward the injection point and the division is created by a web (5) incorporated into the initial stage of the intake passage and exhibiting an upturned pear-drop profile when seen in section.
Patent ES-2104533-T1 (ES)
Title: Volante de vehiculo con un sistema de retencion integrado para ocupantes de vehiculos.
Inventor: HEILIG ALEXANDER
IPC: B60R21/20
Filed: 1996-11-25
Abstract: UN VOLANTE DE VEHICULO ESTA EQUIPADO CON UN SISTEMA DE PROTECCION DE OCUPANTES DEL VEHICULO INTEGRADO, QUE SE COMPONE DE UN GENERADOR (22) DE GAS CON UN TRAMO (26) DE SUJECION Y UN SACO (24) DE GAS CON UNA ABERTURA DE SOPLADO, Y LA ZONA DE BORDE FORMA UN TRAMO (28) SOPORTE. EL VOLANTE (10) DE VEHICULO EN SI MISMO SE COMPONE DE UN CUBO (12) Y UN CUERPO (14) DE VOLANTE CON UNA COBERTURA (34) DE SACO DE GAS, QUE ES COMPONENTE INTEGRAL DEL CUERPO (14) DE VOLANTE. EN EL CUBO (12) SE CONFIGURA UNA SUPERFICIE (16) DE SUJECION Y EN EL CUERPO (14) DE VOLANTE UNA SUPERFICIE (18) DE APOYO. EL CUBO (12) ESTA SUJETO CON EL CUERPO (14) DE VOLANTE DE TAL MODO QUE EL TRAMO (28) DE APOYO DEL SACO DE GAS Y EL TRAMO (26) DE SUJECION DEL GENERADOR DE GAS SE PEGAN ENTRE LA SUPERFICIE (18) SOPORTE DEL CUERPO DE VOLANTE Y LA SUPERFICIE (16) DE SUJECION DEL CUBO.
Patent ES-2132049-T1 (ES)
Title: Microcontrolador que comprende un numero minimo de componentes externos.
Inventor: HULL RICHARD L
IPC: G06F1/24
Filed: 1997-05-21
Abstract: LA PRESENTE INVENCION ESTA RELACIONADA CON UN MICROCONTROLADOR QUE PUEDE SER CONFIGURADO PARA FUNCIONAR SIN SER ACOMPAÑADO POR NINGUN COMPONENTE EXTERNO. EL MICROCONTROLADOR PUEDE FUNCIONAR DE UN MODO CORRECTO A PARTIR DE LA APLICACION UNICAMENTE DE POTENCIA Y LINEAS DE SEÑAL, SIN QUE SEA NECESARIO UN COMPONENTE EXTERNO. EL MICROCONTROLADOR (10) TIENE UN SISTEMA DE CIRCUITOS DE REPOSICIONAMIENTO (14) Y OSCILADOR (16) INTERNO INTEGRADO EN EL MICROCONTROLADOR. EL MICROCONTROLADOR TIENE TAMBIEN COMPONENTES EXTERNOS SIMPLES INTEGRADOS COMO REOSTATOS DE LIMITACION DE CORRIENTE EN EL INTERIOR.
Patent CY-1109836-T1 (CY)
Title: Διαμινοπαραγωγα βιοτινης και τα συζυγιακα τους με μακροκυκλικους χηλικους παραγοντεσς
Inventor: CARMINATI PAOLO
IPC: A61K51/04
Filed: 2010-02-02
Abstract: Περιγράφονται ενώσεις του τύπου (I): Τύπος (I) όπου οι ρίζες είναι όπως ορίζονται στην περιγραφή, διαδικασίες για την παρασκευή τους και οι χρήσεις αυτών για την παρασκευή των συζυγιακών με ραδιονουκλίδια για χρήση σε θεραπείες ανθρώπων και ζώων και διαγνωστικές διαδικασίες, ιδίως για τη διάγνωση και θεραπεία παθολογικών καταστάσεων όπως οι όγκοι.
Patent CY-1112023-T1 (CY)
Title: Φαρμακοτεχνικη μορφη νιτροοξυπαραγωγων των nsaids
Inventor: GASSLANDER ULLA
IPC: A61K47/18
Filed: 2011-01-07
Abstract: Η παρούσα εφεύρεση αφορά φαρμακοτεχνική μορφή περιλαμβάνουσα: α) ένα ή περισσότερα NSAID(s) απελευθέρωσης NO του τύπου (I), β) ένα ή περισσότερα επιφανειοδραστικά, γ) ένωση σαρωτή καρβονυλίου που επιλέγεται από μορφές ελευθέρου οξέος, άλατα, παράγωγα εστέρων καρβοξυλικού οξέος μιας ένωσης του τύπου (II): Η2Ν-(CH2)m-(C6H4)-COOH όπου το m = 0-10 και δ) προαιρετικά ένα έλαιο ή ημι-στερεό λίπος ή/και αλκοόλη βραχείας αλύσου.
Patent CY-1111615-T1 (CY)
Title: Αρυλβινυλαζακυκλοαλκανια και μεθοδοι παρασκευης και χρησεως τους.
Inventor: GENEVOIS-BORELLA ARIELLE
IPC: C07D405/14
Filed: 2011-04-05
Abstract: Αποκαλύπτεται το βινυλαζακυκλοαλκάνιο 3-(2-πυρρολιδιν-3-υλβινυλ)-5-(τετραϋδροπυραν-4-υλοξυ)πυριδίνη. Η ένωση είναι ένα πρόσδεμα των nAChR. Η ένωση και τα φαρμακευτικά αποδεκτά άλατα της μπορεί να χρησιμοποιηθεί για την παρασκευή φαρμακευτικών συνθέσεων και/ή φαρμάκων προοριζόμενων για την πρόληψη ή την αγωγή διαταραχών σχετιζόμενων με δυσλειτουργία του nAChR, ιδιαίτερα εντός του κεντρικού νευρικού συστήματος ή του γαστρεντερικού συστήματος. Παραδείγματα τύπων διαταραχών οι οποίες μπορούν να αντιμετωπισθούν περιλαμβάνουν νευροεκφυλιστικές διαταραχές, περιλαμβανομένων διαταραχών του κεντρικού νευρικού συστήματος όπως η νόσος του Alzheimer, νοητικές διαταραχές, κινητικές διαταραχές όπως η νόσος του Parkinson, τον εθισμό σε φάρμακα, διαταραχές της συμπεριφοράς και φλεγμονώδεις διαταραχές εντός του γαστρεντερικού συστήματος. Η ένωση μπορεί επίσης να χρησιμεύσει ως αναλγητικά στην αγωγή του οξέως, χρόνιου ή υποτροπιάζοντος άλγους.
Patent CY-1113348-T1 (CY)
Inventor: BLOMS-FUNKE PETRA
IPC: A61K31/35
Filed: 2011-06-21
Abstract: The use of eleven specific C-(2-phenyl-cyclohexyl)-methylamine compounds (I) (all preferably in 1R,2R-enantiomer form), e.g. 3-(2-dimethylaminomethyl-cyclohexyl)-phenol (Ia) or (2-(3-methoxyphenyl)-cyclohexylmethyl)-dimethylamine, as medicaments for treating anxiety disorders or as adjuvant for standard antidepressants is new. The use of C-(2-phenyl-cyclohexyl)-methylamine compounds (I) is claimed in the production of medicaments for treating anxiety disorders and in the production of adjuvants for standard antidepressants. (I) is selected from 3-(2-dimethylaminomethyl-cyclohexyl)-phenol (Ia), (2-(3-methoxyphenyl)-cyclohexylmethyl)-dimethylamine, sulfuric acid mono-(3-(2-dimethylaminomethyl-cyclohexyl)-phenyl) ester, 3-(2-methylaminomethyl-cyclohexyl)-phenol, 3-(2-dimethylaminomethyl-cyclohexyl)-phenol N-oxide, 6-(3-(2-dimethylaminomethyl-cyclohexyl)-phenoxy)-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid, 4-(2-dimethylaminomethyl-cyclohexyl)-catechol, 3-(2-aminomethyl-cyclohexyl)-phenol, C-(2-(3-methoxyphenyl)-cyclohexyl)-methylamine, (2-(3-methoxyphenyl)-cyclohexylmethyl)-methylamine and (2-(3-methoxyphenyl)-cyclohexylmethyl)-dimethylamine N-oxide. All compounds are optionally in the form of racemates or pure stereoisomers (specifically enantiomers or diastereomers) or their mixtures in all proportions; and/or in the form of salts or solvates (specifically hydrates). (I) are preferably in 1R,2R-enantiomer form. ACTIVITY : Tranquilizer; antidepressant; analgesic. In 'elevated plus maze' tests for anxiolytic activity in rats (see Psychopharmagcology, 2002, 163, 121-141), 3-(2-dimethylaminomethyl-cyclohexyl)-phenol (Ia) gave residence time of 118.2 seconds at a dose of 16 mg/kg, compared with 16.8 seconds in vehicle-only controls. MECHANISM OF ACTION : psi -Opiate agonist; serotonin reuptake inhibitor; noradrenaline reuptake inhibitor. (Ia) had K i values of 0.14 mu M, 0.05 mu M and 0.16 mu M in mu -opioid affinity, serotonin reuptake inhibiting and noradrenaline reuptake inhibiting assays respectively.
Patent CY-1112039-T1 (CY)
Inventor: GRIMLER DOMINIQUE
IPC: C07D261/20
Filed: 2011-11-02
Abstract: Pharmaceutical compositions and medical uses of comprising either (R)-1-(4-{3-[4-(6-fouoro-benzo(d)isoxazol-3-yl)-piperidin-1-yl]-propoxy}-3-methoxy-phenyl)ethanol of formula I:   
or a pharmaceutically acceptable salt thereof, 
or (S)-1-(4-{3-[4-(6-fouoro-benzo(d)isoxazol-3-yl)-piperidin-1-yl]-propoxy}-3-methoxyphenyl)ethanol of formula II:   
or a pharmaceutically acceptable salt thereof.
Patent CY-1116640-T1 (CY)
Title: Φαρμακευτικο παρασκευασμα που περιεχει οξυκωδονη και ναλοξονη
Inventor: BRÖGMANN Bianca
IPC: A61K47/02
Filed: 2015-08-25
Abstract: Η εφεύρεση αφορά ένα σταθερό σε αποθήκευση φαρμακευτικό παρασκεύασμα που περιλαμβάνει οξυκωδόνη και ναλοξόνη για χρήση στην θεραπεία πόνου, με τις δραστικές ενώσεις να απελευθερώνονται από το παρασκεύασμα με παρατεταμένο, αμετάβλητο και ανεξάρτητο τρόπο.
Patent CY-1122987-T1 (CY)
Title: Αντισωματα εναντι αμυλοειδους βητα
Inventor: GROVES MARIA
IPC: A61P25/28
Filed: 2020-06-11
Abstract: Αντίσωμα για ανθρώπινο αμυλοειδές βήτα. Το αντίσωμα εκλεκτικά δεσμεύει ανθρώπινο αμυλοειδές βήτα 42 πεπτίδιο έναντι ανθρώπινου αμυλοειδούς βήτα 40 πεπτιδίου. Αντισώματα ειδικά για αμυλοειδές βήτα 42 ως θεραπευτικοί παράγοντες για δέσμευση αμυλοειδούς βήτα 42 πεπτιδίου και αγωγή παθήσεων που συνδέονται με αμυλοείδωση όπως της νόσου του Alzheimer.
Patent HR-P20090596-T1 (HR)
Title: Cover film for blister package
Inventor: PIESSLINGER JOHANNES
IPC: B65D75/36
Filed: 2009-11-06
Abstract: The blister cover foil is sealed against the blister base foil to provide packaging in which the product is visible. It consists of at least the following layers: preliminary compressed lacquer layer; compressed base layer; adhesive layer; plastic foil layer; peeling adhesive layer; aluminum layer; and hot seal lacquer layer. The compressed base layer is made of aluminum.
Patent HR-P20110529-T1 (HR)
Inventor: SWINNEN DOMINIQUE
IPC: C07D295/18
Filed: 2011-07-13
Abstract: Derivat N-hidroksiamida prema formuli (I), naznačen time da A je odabran od -C(B)- i N; B je H ili B tvori vezu sa bilo R5 ili R7;R1 je odabran od H, C1-C6 alkila, C2-C6 alkenila, C2-C6 alkinila, C3-C8-cikloalkila, heterocikloalkila, arila, heteroarila, C3-C8-cikloalkil C1-C6 alkila, heterocikloalkil C1-C6 alkila, heteroaril C1-C6 alkila, amino i alkoksi; R2 je H; R3 je odabran od H, C1-C6 alkila, C2-C6 alkenila i C2-C6 alkinila; R4, R5 , R6 i R7 su nezavisno odabrani od H, C1-C6 alkila, C2-C6 alkenila, C2-C6 alkinila; ili R4 i R7 zajedno tvore -CH2- vezu; kao i njegovi optički aktivni oblici kao enantiomeri, diastereomeri i njegovi oblici racemata, kao i njegove farmaceutski prihvatljive soli. Patent sadrži još 20 patentnih zahtjeva.
Patent HR-P20120577-T1 (HR)
Title: 3,4-diarylpyrazoles as protein kinase inhibitors
Inventor: MAURIZIO PULICI
IPC: A61P35/00
Filed: 2012-07-12
Abstract: 3,4-diarylpyrazole derivatives of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
Patent SI-1645558-T1 (SI)
Title: Piperazinylpyrazines as serotonin 5-HT2C receptor modulators
Inventor: CERNERUD MAGNUS
IPC: A61P3/04
Filed: 2003-06-18
Abstract: The present invention relates to compounds which are therapeutically active in the central nervous system.  In one aspect, the invention relates to certain compounds of the general formula (I):     Another object of the present invention is the use of said compound to manufacture a medicament for the treatment of a serotonin-related disorder.
Patent SI-1525313-T1 (SI)
Title: Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase
Inventor: BROWNLIE JOHN
IPC: C12P21/08
Filed: 2003-07-01
Abstract: A canine respiratory coronavirus (CRCV) that is present in the respiratory tract of dogs with canine infectious respiratory disease and which has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43.  The CRCV spike, polymerase and hemagglutinin/esterase cDNA and protein partial sequences are listed in Figures 1 to 4, 13 and 14.
Patent SI-1670444-T1 (SI)
Title: Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
Inventor: GILLESSEN HUBERT JEAN-MARIE FRANCOIS
IPC: C07D209/18
Filed: 2003-10-03
Abstract: The present disclosure relates to the use of one or more compounds that are capable of increasing the serum level of insulin-like growth factor 1 (IGF-1) for the preparation of a therapeutical composition, in particular, in the form of a food supplement, for the treatment of subjects suffering from serious fatigue and exhausting symptoms, burn-out and chronic fatigue syndrome. The same composition can also be used by patients suffering from depression, Alzheimer disease, irritated bowel syndrome, osteoporosis, type 2 diabetes, or for anti-aging, immune therapy and recovery after exercise. The composition also has a use in veterinary applications for increasing the growth and immunity in animals.
Patent SI-1787916-T1 (SI)
Title: Receptacle with a lid
Inventor: D AMATO GIANFRANCO
IPC: B65D43/02
Filed: 2005-11-18
Abstract: The present invention is directed to a lid (5) with a central lid portion (6) and with a peripheral clamping groove (7) formed between an outer groove wall (8) and an inner groove wall (9) for being clamped onto a beaded rim (4) of a cup-shaped receptacle (1). A constriction (10) is provided on at least a peripheral section of the outer groove wall (8), the constriction (10) forming a projection (14) into the interior of the groove (7), this projection (14) comprising a projecting tip (15), an upper wall (16) and a lower wall (17), and the projecting tip (15) defining a horizontal plane (H). The invention is characterized in that an angle (±) between the horizontal plane (H) and a tangential plane (T16) to the end of the upper wall (16) adjacent the projecting tip (15) is smaller than an angle (¸) between the horizontal plane (H) and a tangential plane (T17) to the end of the lower wall (17) adjacent the projecting tip (15).
Patent SI-1988909-T1 (SI)
Title: Use of polyethylene glycol in inflammation related topical disorders or diseases and wound healing
Inventor: VAN DEN PLAS DAVE
IPC: A61K31/00
Filed: 2007-07-30
Abstract: The present invention relates to hydrogel compositions or aqueous solutions comprising one or more forms of Poly-ethylene Glycol, for use as medicaments, more particularly for topical application in the treatment of wounds, for the treatment of inflammatory skin disease and in particular for the prevention of scar formation and/or for enhancing the repair of damaged skin or mucosa.
Patent SI-2340038-T1 (SI)
Title: Biochemically stabilized hiv-1 env trimer vaccine
Inventor: HARRISON STEPHEN C
IPC: A61K39/00
Filed: 2009-10-13
Abstract: Stabilized trimers of a clade A strain and a clade C strain of HIV-1 are provided. Broadly neutralizing antisera against HIV-1, methods of making broadly neutralizing antisera against HIV-1, broadly neutralizing vaccines against HIV-1, as well as methods of treating subjects infected with HIV, preventing HIV infection, and inhibiting HIV-mediated activities are also provided.
Patent TR-201009989-T1 (TR)
Title: Sargı nakış makinesi için besleme aygıtı
Inventor: YUAN WEIQING
IPC: D05B25/00
Filed: 2010-12-01
Abstract: Bir ip nakletme mekanizmasını ve ip nakletme mekanizmasını işe götüren bir tahrik mekanizmasını içeren bir sargı nakış besleme aygıtı açıklanmaktadır . Hareket edebilir şekilde iğne milini bir tarafta motor tabanına bağlayan ve diğer tarafta bir kılavuz çark ile donatılmış olan bir salınım çubuğuna, ve iğne miline yakın bir yeniden konumlandırma yayını içeren bir nakış ipini germe mekanizmasına sahiptir . Yeniden konumlandırma yayının diğer tarafı, morto tabanına sabitlenmiştir olup iğne milinin bir tarafında düzenlenmiş ip geri çekme için bir fotokuplör asamblesine, ip verme için bir fotokuplör asamblesine ve bir kodlayıcı diski içeren ip geri çekme ve vermenin bir izleme mekanizmasına sahiptir . Radyal yön boyunca kodlayıcı disk üzerinde düzenlenmiş fotik aralık alanı, sırasıyla motor tabanında düzenlenmiş ip geri çekme için fotokuplör asamblesi ve ip verme için fotokuplör asamblesine karşılık gelmektedir ve bilgisayarın kontrol sistemine bağlıdır . Bir geri çekme ve verme motoru, geri çekme ve verme motorunun çıkış şaftı tarafında düzenlenmiş ip nakletmenin bir sürücü çarkı ve ip nakletmenin sürücü çarkının bir tarafında düzenlenmiş ip nakletmenin bir sürülen çarkını içeren bir ip geri çekme ve verme mekanizmasını içermektedir .